[ad_1]
Toronto –
Justin De Four commented: “We are very excited about the new direction of the company and increasing shareholder value through continual operations in an industry that is showing explosive growth.”
According to Report Linker the global market for disinfectants estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$8.3 Billion by 2027, growing at CAGR of 6.2% over the period 2020-2027. BioLife has acquired new technologies and processes that are implemented to mitigate the spread of harmful microbes and viruses using innovative solutions.
About BioLife Sciences Inc.
BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products, non-contact human temperature screening technology, and touchless vending/marketplaces.
www.biolifesciences.com
ir@biolifesciences.com
US +1 775 9810270
CA +1 647 5586663
[ad_2]